[1] GRAMIAK R，SHAH PM，KRAMER DH. Ultrasound cardiography:contrast studies in anatomy and function[J]. Radiology， 1969，92（5）:939-948.
[2] MATSUDA Y，YABUUCHI I. Hepatic tumors:US contrast enhancement with CO2 microbubbles[J]. Radiology，1986，161（3）:701-705.
[3] LEEN E，ANGERSON WJ，YARMENITIS S，et al. Multi-centre clinical study evaluating the efficacy of SonoVue，a new ultrasound contrast agent in Doppler investi- gation of focal hepatic lesions[J]. Eur J Radiol，2002，41（3）:200-206.
[4] ALBRECHT T，BLOMLEY M，BOLONDI L，et al. Guidelines for the use of contrast agents in ultrasound[J]. Ultraschall Med，2004，25（4）:249-256.
[5] QUAIA E，CALLIADA F，BERTOLOTTO M，et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride filled microbubble contrast agent:diagnostic performance and confidence[J]. Radiology，2004，232（2）:420-430.
[6] FAN ZH，CHEN MH，DAI Y，et al. Evaluation of the primary malignancies in the liver using contrast-enhanced sonography:correlation with pathology[J]. Am J Roentgenol，2006，186（6）:1512-1519.
[7] WILSON SR，BURNS PN. An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography[J]. Am J Roentgenol，2006，186（5）:1401-1412.
[8] LEEN E，CECCOTTI P，KALOGEROPOULOU C，et al. Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography[J]. Am J Roentgenol，2006，186（6）:1551-1559.
[9] JANG HJ，KIMTK，BURNS P，et al. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US:comparison with histologic differentiation[J]. Radiology，2007，244（3）:898-906.
[10] KIM TK，KIM AY，CHOI BI. Hepatocellular carcinoma: harmonic ultrasound and contrast agent[J]. Abdom Imaging， 2002，27（2）:129-138.
[11] LENCIONI R. Impact of European Federation of Societies for Ultrasound in Medicine and Biology（EFSUMB）guidelines on the use of contrast agents in liver ultrasound[J]. Eur Radiol，2006，16（7）:1610-1613.
[12] JANG HJ，KIM TK，WILSON SR. Small nodules（1 2cm）in liver cirrhosis:Characterization with contrast-enhanced ultrasound[J]. Eur J Radiol[J]. 2009，72（3）:418-424.
[13] JANG HJ，KIM TK，WILSON SR. Imaging of malignant liver masses: characterization and detection[J]. Ult rasound Q，2006，22（1）:19-29.
[14] 王文平，李超伦，丁红，等. 转移性肝癌的实时超声造影诊断[J]. 中华超声影像学杂志，2008，17（2）:127-129.
[15] CHEN MH，YANG W，YAN K，et a1. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation[J]. Clin Radiol，2007，62（8）:752-760.
[16] VON HERBAY A，VOGT C，WILLERS R，et a1. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions[J]. Ultrasound Med，2004，23（12）:1557-1568.
[17] NICOLAU C，CATAL V，VILANA R，et a1. Evaluation of hepatoceIlula carcinoma using SonoVue，asecond generation ultrasound contrast agent；correlation with cellular differentiation[J]. Eur Radiol，2004，14（6）:1092-1099.
[18] LIU GJ，XU HX，LU MD，et al. Correlation between enhancement pattern of hepatocellular carcinoma on real-time contrast-enhanced ultrasound and tumour cellular differentiation on histopathology[J]. Br Jradiol，2007，80（953）:321-330.
[19] WANG WP，WU Y，LUO Y，et a1. Clinical value of contrast-enhanced ultrasonography in the characterization of focal liver lesions: a prospective multicenter trial[J]. Hepatobiliary Pancreat Dis Int，2009，8（4）:370-376.
[20] FORNER A，VILANA R，AYUSO C，et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma[J]. Hepatology，2008，47（1）:97-104
[21] DAI Y，CHEN MH，FAN ZH，et a1. Diagnosis of small hepatic nodules detected by surveillance ultrasound in patients with cirrhosis:comparison between contrast-enhanced ultrasound and contrast-enhanced helical computed tomography[J]. Hepatol Res，2008，38（3）:281-290.
[22] BRUIX J，SHERMAN M. Management of hepatocellular carcinoma[J]. Hepatology，2005，42（5）:1208-1236.
[23] BEATON C，COCHLIN D， KUMAR N. Contrast enhanced ultrasound should be the initial radiological investigation to characterise focal liver lesions[J]. Eur J Surg Oncol，2010，36（1）:43-46.
[24] WU H，LU Q，LUO Y，et al. Application of contrast-enhanced intraoperative ultrasonography in the decision-making about hepatocellular carcinoma operation[J]. World J Gastroenterol，2010，16（4）:508-512.
[25] SALVAGGIO G，CAMPISI A，GRECO VL，et al. Evaluation of posttreatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT[J]. Abdom Imaging，2010，35（4）:447-453.
[26] RICCI P，CANTISANI V，DRUDI F，et al. Is Contrast-enhanced US alternative to spiral CT in the assessment of treatment outcome of radiofrequency ablation in hepatocellular carcinoma[J]. Ultraschallin Med，2009，30（3）:252-258.
[27] NICOLAU C，VILANA R，BIANCHI L，et al. Early-stage hepatocellular carcinoma:the high accuracy of real-time contrast-enhanced ultrasonography in the assessment of response to percutaneous treatment[J]. Eur Radiol，2007，17（Suppl 6）:F80-88. |
